美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

美國抗疫概念

1,476.81

+5.970.41%

漲家數：10

跌家數：8

平家數：1

市盈率：- -

高：1,484.26

開：1,470.85

低：1,469.38

收：1,470.74

成交量：1.03億

成交額：32.50億

市值：1.21萬億

流通市值：1.19萬億

資料載入中...

Co-Diagnostics, Inc.宣佈380萬美元註冊直接發行普通股按納斯達克規則市價定價

阿斯利康(AZN.US)哮喘三聯療法“布地格福吸入氣霧劑”在華申報上市

Icotrokinra在首次報告的頭對頭試驗中顯示出優於Deucravacitinib的療效強化了這一新型靶向口服肽類藥物治療斑塊性銀屑病的前景

小摩上調吉利德科學目標價至145美元

阿斯利康明星哮喘藥物Fasenra治療COPD晚期研究未達主要終點

莫德納尾盤上漲4.8%

环球市场播报

Co-Diagnostics Inc.與沙特阿拉伯王國合作伙伴簽署戰略合作備忘錄，將Co-Dx™ PCR平台引入中東地區

阿斯利康(AZN)盤前股價挫近2% 據報公司暫停劍橋2億英鎊擴建計劃

阿斯利康股價下跌3%。

這個板塊的健康恐慌有多嚴重？

BUZZ-韓國達成眼科基因療法許可協議後，Ocugen 公司業績增長

英特爾：完成向SILVER LAKE出售ALTERA股份。

Ocugen公司與韓國廣東製藥完成OCU400視網膜色素變性調節性基因療法許可協議

疫苗安全性爭議重燃致美股生物科技股下挫花旗發佈謹慎展望

英國工廠擴張計劃暫停後阿斯利康股價下跌3.05%。

行業研究週報：降息預期強化，工業金屬和貴金屬共振丨天風金屬材料劉奕町團隊

町说金属与新材料

奔馳確認將逐步棄用“EQ”品牌，未來轉向“Electric”命名

超級富豪現在的投資方向

傳特朗普政府計劃指控新冠疫苗導致25名兒童死亡輝瑞(PFE.US)、Moderna(MRNA.US)股價大跌

阿斯利康暫停在英國研發設施的2.71億美元投資。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK4568/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"美國抗疫概念","latestPrice":1476.711,"timestamp":1758138984601,"preClose":1470.7393,"halted":0,"volume":103181772,"delay":0,"changeRate":0.00406,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":5.971802,"latestTime":"09-17 15:56:24 EDT","open":1470.8473,"high":1484.2612,"low":1469.3794,"amount":3249599365.434433,"amplitude":0.010119,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1758139200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.836858,"peRate":20.735352,"turnoverRate":0.006718,"increases":10,"decrements":8,"flats":1,"marketCap":1211445303164,"floatMarketCap":1192244836156},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1484.2612,"amplitude":0.010119,"preClose":1470.7393,"low":1469.3794,"pbRate":"3.836858","latestPrice":1476.81,"volume":103162125,"delay":0,"open":1470.8473,"prevYearClose":1274.8187,"prevWeekClose":1488.5051,"prevMonthClose":1489.44,"prevQuarterClose":1377.5769,"fiveDayClose":1484.1697,"twentyDayClose":1501.6229,"sixtyDayClose":1360.6882,"secType":"PLATE","market":"US","turnoverRate":0.006716,"peRate":20.735352,"marketCap":1211517679264,"floatMarketCap":1192316754411,"timestamp":1758138979439,"nameCN":"美國抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":10,"down":8,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1105601568","title":"Co-Diagnostics, Inc.宣佈380萬美元註冊直接發行普通股按納斯達克規則市價定價","url":"https://stock-news.laohu8.com/highlight/detail?id=1105601568","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105601568?lang=zh_tw&edition=fundamental","pubTime":"2025-09-17 21:48","pubTimestamp":1758116896,"startTime":"0","endTime":"0","summary":"Co-Diagnostics, Inc.宣布完成380万美元注册直接发行普通股的定价，此次发行严格按照纳斯达克交易所规则进行市价定价。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CODX","BK4082","BK4568"],"gpt_icon":0},{"id":"2568645499","title":"阿斯利康(AZN.US)哮喘三聯療法“布地格福吸入氣霧劑”在華申報上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2568645499","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568645499?lang=zh_tw&edition=fundamental","pubTime":"2025-09-17 20:56","pubTimestamp":1758113762,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，9月17日，CDE网站显示，阿斯利康的布地格福吸入气雾剂在华申报新适应症。布地格福吸入气雾剂是阿斯利康开发的一款固定剂量三联疗法，包含布地奈德、格隆溴铵、福莫特罗三种药物活性成分。今年5月，阿斯利康宣布布地格福吸入气雾剂治疗哮喘的两项III期研究达到主要终点。结果显示，相较于Symbicort组，布地格福吸入气雾剂组患者的1秒内用力呼气量显著改善，并且重度哮喘恶化发生率显著降低。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1346478.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"阿斯利康(AZN.US)哮喘三联疗法“布地格福吸入气雾剂”在华申报上市","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AZN","LU0889565916.HKD","BK4585","BK4588","LU0109394709.USD","LU2456880835.USD","LU2417539215.USD","LU2236285917.USD","BK4568","LU0320765992.SGD","LU1829250122.USD","BK4007","LU2462157665.USD"],"gpt_icon":0},{"id":"1138820125","title":"Icotrokinra在首次報告的頭對頭試驗中顯示出優於Deucravacitinib的療效 強化了這一新型靶向口服肽類藥物治療斑塊性銀屑病的前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1138820125","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138820125?lang=zh_tw&edition=fundamental","pubTime":"2025-09-17 20:01","pubTimestamp":1758110494,"startTime":"0","endTime":"0","summary":"Icotrokinra在首次报告的头对头试验中显示出优于Deucravacitinib的疗效，强化了这一新型靶向口服肽类药物治疗斑块性银屑病的前景。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU1894683348.USD","IE00BJJMRZ35.SGD","LU2468319806.SGD","LU2471134952.CNY","LU0345770993.USD","LU0203345920.USD","LU2089984988.USD","LU1914381329.SGD","LU0320765646.SGD","LU0234570918.USD","LU2505996681.GBP","BK4592","LU1267930813.SGD","LU0795875086.SGD","LU1196500208.SGD","BK4534","BK4550","LU0466842654.USD","LU1718418525.SGD","LU1066051498.USD","BK4588","IE00BFTCPJ56.SGD","LU2750360997.AUD","LU0345769631.USD","LU2430703178.SGD","LU1032466523.USD","BK4581","SG9999002232.USD","LU2133065610.SGD","IE00BJT1NW94.SGD","IE00BFXG1179.USD","LU0070217475.USD","LU0795875169.SGD","SG9999002224.SGD","LU0792757196.USD","IE00B1BXHZ80.USD","IE0009355771.USD","LU0203347892.USD","LU0882574055.USD","LU1674673428.USD","IE00B2B36J28.USD","LU2471134879.HKD","SG9999001440.SGD","BK4532","LU1261432733.SGD","IE0002270589.USD","LU1032955483.USD","LU1244550577.SGD","LU1894683264.USD","IE00BVYPNW00.USD","LU0098860793.USD","LU1935042991.SGD","LU0640476718.USD","LU1162221912.USD","IE00B4R5TH58.HKD","IE00B3PB1722.GBP","LU2129689605.HKD","LU1585245621.USD","LU1778281490.HKD","BK4568","IE00BBT3K403.USD","LU1506573853.SGD","BK4533","BK4559","LU2471134796.USD","IE00BLSP4452.SGD","LU2505996509.AUD","IE00B3T34201.USD","LU0058720904.USD","LU0234572021.USD","LU2471134523.USD","LU0345769128.USD","LU1280957306.USD","IE0034235303.USD","JNJ","LU0289739699.SGD","LU1066051225.USD","LU2129689431.USD","IE0002141913.USD","IE00BN8TJ469.HKD","LU0345770308.USD","IE00BGHQF631.EUR","LU0889566641.SGD","IE00BVYPNV92.GBP","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","BK4585","LU1066053197.SGD","IE000M9KFDE8.USD","LU1732800096.USD","LU2430703251.USD","BK4504","LU0432979614.USD","LU0912757837.SGD","LU1430594728.SGD","LU1057294990.SGD","LU0985320562.USD","LU1059921491.USD","LU1674673691.USD","LU2347655156.SGD","LU2592432038.USD","LU1023059063.AUD","LU0122379950.USD","LU2750360641.GBP","LU2112291526.USD","LU2602419157.SGD","LU1066051811.HKD","LU1221951129.SGD","LU0114720955.EUR","IE00B19Z3581.USD","LU1929549753.HKD","LU1244550494.USD","LU2129689514.USD","LU1221951046.USD","IE00B7SZLL34.SGD","LU1244550221.USD","IE00BLSP4239.USD","LU1061106388.HKD","LU1732799900.SGD","IE00BDGV0183.EUR","LU1074936037.SGD","LU2430703095.HKD","IE00B42XCP33.USD"],"gpt_icon":0},{"id":"2568464200","title":"小摩上調吉利德科學目標價至145美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2568464200","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568464200?lang=zh_tw&edition=fundamental","pubTime":"2025-09-17 17:40","pubTimestamp":1758102013,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4550","BK4139","LU0289739699.SGD","LU0114720955.EUR","BK4568","BK4585","LU0109394709.USD","IE0002270589.USD","IE00B3T34201.USD","SG9999015945.SGD","GILD","SG9999015978.USD","LU1585245621.USD","LU1571399168.USD","LU0320765992.SGD","LU0882574055.USD","LU2087621335.USD","LU1674673691.USD","BK4578","IE00BKVL7J92.USD","SG9999015952.SGD","BK4532","LU1839511570.USD","IE00BSNM7G36.USD","BK4583","BK4566","LU1430594728.SGD","SG9999015986.USD","LU2089984988.USD","LU1066053197.SGD","LU0823416689.USD","IE00BZ1G4Q59.USD","LU1778281490.HKD","LU0889565916.HKD","LU1066051498.USD","IE00B19Z3B42.SGD","LU2468319806.SGD","BK4588","LU1674673428.USD","LU2324357040.USD","LU0234570918.USD","LU0058720904.USD","IE00B7SZLL34.SGD","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"2568469179","title":"阿斯利康明星哮喘藥物Fasenra治療COPD晚期研究未達主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2568469179","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568469179?lang=zh_tw&edition=fundamental","pubTime":"2025-09-17 17:07","pubTimestamp":1758100024,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，阿斯利康周三表示，其哮喘药物Fasenra在一项针对慢性阻塞性肺疾病患者的晚期研究中未能控制病情急性发作的发生率。据悉，Fasenra是阿斯利康第二畅销的呼吸和免疫药物。阿斯利康表示，与安慰剂相比，Fasenra未能在研究中达到主要终点，并补充称将对完整的研究数据进行分析，以更好地理解结果。此外，阿斯利康宣布，其罕见病药物Saphnelo在一项后期临床试验中成功达到主要终点，能够显著降低系统性红斑狼疮的活动度。","market":"fut","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1346311.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2236285917.USD","LU1829250122.USD","LU2462157665.USD","LU0320765992.SGD","AZN","BK4568","LU2417539215.USD","BK4585","LU0889565916.HKD","BK4007","BK4588","LU0109394709.USD","LU2456880835.USD"],"gpt_icon":0},{"id":"2568438724","title":"莫德納尾盤上漲4.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568438724","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568438724?lang=zh_tw&edition=fundamental","pubTime":"2025-09-17 03:46","pubTimestamp":1758051960,"startTime":"0","endTime":"0","summary":"标普500指数成份股莫德纳（MRNA）上涨4.8%，延续了周一的反弹上涨势头。上周五美股疫苗板块普遍下挫，原因是特朗普政府卫生官员计划在本周向美国疾病控制与预防中心（CDC）下属的一个重要疫苗咨询委员会提出新冠疫苗与25名儿童死亡案例相关的主张。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-09-17/doc-infqtqhz5404327.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4585","BK4534","BK4501","BK4551","BK4533","BK4532","CDC","BK4568","BK4548","MRNA","BK4588","BK4139"],"gpt_icon":0},{"id":"1100419826","title":"Co-Diagnostics Inc.與沙特阿拉伯王國合作伙伴簽署戰略合作備忘錄，將Co-Dx™ PCR平台引入中東地區","url":"https://stock-news.laohu8.com/highlight/detail?id=1100419826","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100419826?lang=zh_tw&edition=fundamental","pubTime":"2025-09-16 21:31","pubTimestamp":1758029491,"startTime":"0","endTime":"0","summary":"Co-Diagnostics Inc.与沙特阿拉伯王国合作伙伴签署战略合作备忘录，将Co-Dx™ PCR平台引入中东地区","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4082","CODX"],"gpt_icon":0},{"id":"2567911933","title":"阿斯利康(AZN)盤前股價挫近2% 據報公司暫停劍橋2億英鎊擴建計劃","url":"https://stock-news.laohu8.com/highlight/detail?id=2567911933","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567911933?lang=zh_tw&edition=fundamental","pubTime":"2025-09-15 19:33","pubTimestamp":1757936030,"startTime":"0","endTime":"0","summary":"金吾财讯 | 阿斯利康(AZN)盘前股价走低，暂跌1.84%，报78.1美元。消息面上，据媒体报道，公司已暂停其位于剑桥的耗资 2 亿英镑的研究基地扩建计划。发言人周五表示：“我们不断重新评估公司的投资需求，并可以确认我们在剑桥的扩张已暂停。此前，这家制药公司于今年早些时候放弃了在默西塞德郡投资 4.5 亿英镑建造疫苗工厂的计划。","market":"other","thumbnail":"https://static.szfiu.com/news/20250107/NTBkMTM1NjQzNTIzMTc=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NTBkMTM1NjQzNTIzMTc=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"292452","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU2462157665.USD","LU0320765992.SGD","AZN","LU2417539215.USD","LU1829250122.USD","BK4588","BK4007","LU2236285917.USD","LU0109394709.USD","BK4585","LU2456880835.USD","BK4568"],"gpt_icon":0},{"id":"2567116699","title":"阿斯利康股價下跌3%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2567116699","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567116699?lang=zh_tw&edition=fundamental","pubTime":"2025-09-15 19:22","pubTimestamp":1757935346,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","LU2236285917.USD","BK4585","BK4007","LU0109394709.USD","LU2417539215.USD","AZN","LU0320765992.SGD","LU0889565916.HKD","LU2456880835.USD","LU1829250122.USD","BK4568","LU2462157665.USD"],"gpt_icon":0},{"id":"1101821933","title":"這個板塊的健康恐慌有多嚴重？","url":"https://stock-news.laohu8.com/highlight/detail?id=1101821933","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101821933?lang=zh_tw&edition=fundamental","pubTime":"2025-09-15 18:59","pubTimestamp":1757933960,"startTime":"0","endTime":"0","summary":"向你的经纪人咨询医疗基金投资。如果你对任何成分过敏，请勿购买医疗基金。副作用可能包括迷失方向、情绪低落和突然亏损。经历了一段艰难时期后，一些投资者今年准备忽略警告标签，押注这个受创的板块。例如，资产管理公司Janus Henderson在1月份指出，医疗股指数在两年内落后标普500指数多达53个百分点，创下历史纪录，看起来\"严重被低估\"。例如，周五辉瑞股价下跌4%，此前有报道称美国卫生官员计划将儿童死亡与新冠疫苗联系起来。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0985481810.HKD","LU0456855351.SGD","LU0058720904.USD","SGXZ57979304.SGD","LU1066053197.SGD","FDN","LU0122379950.USD","BK4599","LU0234572021.USD","SG9999013999.USD","SG9999011175.SGD","SG9999002224.SGD","SG9999002232.USD","IE000M9KFDE8.USD","LU0306807586.USD","IE00BLSP4452.SGD","BK4533","BK4007","IE0002270589.USD","LU0225771236.USD","SG9999001176.USD","IE00B19Z3B42.SGD","LU0289739699.SGD","LU0321505868.SGD","BK4588","LU1883839398.USD","LU0868494617.USD","LU1894683348.USD","BK4592","IE00BBT3K403.USD","LU0306806265.USD","LU0321505439.SGD","SG9999001176.SGD","LU1057294990.SGD","LU0170899867.USD","LU1066051498.USD","LU1894683264.USD","IE00B19Z3581.USD","LU1023059063.AUD","BK4568","PFE","SG9999003800.SGD","IE00BLSP4239.USD","BK4534","BK4585","BK4581","LU0225284248.USD","BK4550"],"gpt_icon":1},{"id":"2567115365","title":"BUZZ-韓國達成眼科基因療法許可協議後，Ocugen 公司業績增長","url":"https://stock-news.laohu8.com/highlight/detail?id=2567115365","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567115365?lang=zh_tw&edition=fundamental","pubTime":"2025-09-15 18:57","pubTimestamp":1757933846,"startTime":"0","endTime":"0","summary":"BUZZ-韩国达成眼科基因疗法许可协议后，Ocugen 公司业绩增长9月15日 - ** 药物开发商OcugenOCGN.O股价盘前上涨9.4%，报1.17美元** 该公司与韩国光东制药009290.KS签订了一项许可协议，授权后者在韩国独家使用其用于治疗视网膜色素变性的实验性基因疗法OCU400。** 根据协议，Ocugen 公司将获得高达 750 万美元的前期许可费和近期开发里程碑，在商业化的前十年中，还将获得高达 1.8 亿美元的销售里程碑。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250915:nL3S3V20JG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4568","BK4563","OCGN"],"gpt_icon":0},{"id":"2567088118","title":"英特爾：完成向SILVER LAKE出售ALTERA股份。","url":"https://stock-news.laohu8.com/highlight/detail?id=2567088118","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567088118?lang=zh_tw&edition=fundamental","pubTime":"2025-09-15 18:20","pubTimestamp":1757931644,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4612","BK4568","LU0321505439.SGD","BK4579","BK4534","BK4588","BK4605","BK4575","BK4585","BK4554","BK4515","399300","BK4202","LAKE","LU0321505868.SGD","159982","INTC","IE0031619046.USD","IE00B7SZL793.SGD","IE00B19Z4B17.USD","BK4535","BK4512","LU0081259029.USD","IE00B66KJ199.SGD","LU2543165471.USD","BK4543","BK4602","BK4527","BK4141","LU2148611432.USD","BK4533","BK4529","BK4550"],"gpt_icon":0},{"id":"1135309654","title":"Ocugen公司與韓國廣東製藥完成OCU400視網膜色素變性調節性基因療法許可協議","url":"https://stock-news.laohu8.com/highlight/detail?id=1135309654","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135309654?lang=zh_tw&edition=fundamental","pubTime":"2025-09-15 18:04","pubTimestamp":1757930679,"startTime":"0","endTime":"0","summary":"Ocugen公司与韩国广东制药株式会社宣布完成OCU400调节性基因疗法的许可协议，该疗法用于治疗视网膜色素变性疾病，协议涵盖韩国市场。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OCGN","BK4563","BK4568"],"gpt_icon":0},{"id":"2567675124","title":"疫苗安全性爭議重燃致美股生物科技股下挫 花旗發佈謹慎展望","url":"https://stock-news.laohu8.com/highlight/detail?id=2567675124","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567675124?lang=zh_tw&edition=fundamental","pubTime":"2025-09-15 15:54","pubTimestamp":1757922841,"startTime":"0","endTime":"0","summary":"对此，花旗发布研报称，相关生物科技公司股价因报道承压，再次突显了波动风险。总体而言，鉴于持续存在的新闻波动性，该行对新冠疫苗相关企业的情绪仍持谨慎态度。该行认为该股为“高风险”，原因在于生物科技类股票的典型波动性，以及临床试验和后期药物开发中的不确定性/风险。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250915155614952e7222&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250915155614952e7222&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1894683264.USD","LU0306806265.USD","LU0289739699.SGD","LU0648001328.SGD","LU0130517989.USD","LU0122379950.USD","LU0980610538.SGD","LU0106831901.USD","LU1894683348.USD","LU0225284248.USD","BK4550","LU1244550494.USD","SG9999002224.SGD","SG9999001176.SGD","IE00B19Z3B42.SGD","BK4207","SG9999013999.USD","LU0310800965.SGD","PFE","LU0321505439.SGD","LU2236285917.USD","IE000M9KFDE8.USD","BK4568","BK4581","IE00BLSP4239.USD","LU1057294990.SGD","BK4533","LU0868494617.USD","LU0306807586.USD","LU0985481810.HKD","SGXZ57979304.SGD","BK4566","LU1201861249.SGD","BK4599","LU0225771236.USD","IE00BBT3K403.USD","LU1668664300.SGD","BK4588","LU1066051498.USD","BK4534","LU0098860793.USD","BK4585","LU2456880835.USD","SG9999003800.SGD","BK4504","LU0320765646.SGD","LU1366192091.USD","LU0477156953.USD","LU1066053197.SGD","LU0058720904.USD"],"gpt_icon":1},{"id":"2567419909","title":"英國工廠擴張計劃暫停後阿斯利康股價下跌3.05%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2567419909","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567419909?lang=zh_tw&edition=fundamental","pubTime":"2025-09-15 15:50","pubTimestamp":1757922616,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2236285917.USD","LU0889565916.HKD","AZN","BK4588","LU2417539215.USD","LU2456880835.USD","LU2462157665.USD","LU0320765992.SGD","BK4585","LU1829250122.USD","BK4568","LU0109394709.USD","BK4007"],"gpt_icon":0},{"id":"2567930111","title":"行業研究週報：降息預期強化，工業金屬和貴金屬共振丨天風金屬材料劉奕町團隊","url":"https://stock-news.laohu8.com/highlight/detail?id=2567930111","media":"町说金属与新材料","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567930111?lang=zh_tw&edition=fundamental","pubTime":"2025-09-14 19:05","pubTimestamp":1757847921,"startTime":"0","endTime":"0","summary":"目前美联储9月降息预期愈发强烈，市场情绪在发酵后充分释放，铜价近期走势表现偏强震荡，后续关注9月18日FOMC会议宏观指引。从美国劳动力市场的疲软信号，到美联储降息预期的强化，再到各国央行的持续增持黄金储备，以及美元汇率和债券市场的联动反应，都为金银价格提供了坚实的支撑。因此关注下周美联储会议纪要对市场的影响，以及下周铜加工企业开工有无波动。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250914192217979134f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250914192217979134f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["H","BK4086","BK4585","APT","BK4142","ACH","BK4568","BK4153"],"gpt_icon":0},{"id":"2567186498","title":"奔馳確認將逐步棄用“EQ”品牌，未來轉向“Electric”命名","url":"https://stock-news.laohu8.com/highlight/detail?id=2567186498","media":"IT之家","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567186498?lang=zh_tw&edition=fundamental","pubTime":"2025-09-13 12:18","pubTimestamp":1757737090,"startTime":"0","endTime":"0","summary":"IT之家 9 月 13 日消息，梅赛德斯-奔驰长期以来在电动车型上使用 EQ 子品牌，并推出了 EQS、EQE 轿车及其 SUV 版本。奔驰首席技术官 Markus Schfer 本周二在接受《新闻周刊》采访时确认，公司将逐步放弃 EQ 标识，转而使用“Electric”作为新命名。IT之家提醒，“Electric”对应的中文名可能类似于纯电 CLA、纯电 GLC 这种带有“纯电”的词缀。Schfer 表示：我们正在转向使用 Electric 这一名称。奔驰并不会马上切换命名。奔驰官网的未来车型页面上仍显示 2027 款 GLC with EQ Technology。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8mc2kBWeQTg","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["EQ","BK4139","BK4568"],"gpt_icon":0},{"id":"1116439943","title":"超級富豪現在的投資方向","url":"https://stock-news.laohu8.com/highlight/detail?id=1116439943","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116439943?lang=zh_tw&edition=fundamental","pubTime":"2025-09-13 09:37","pubTimestamp":1757727464,"startTime":"0","endTime":"0","summary":"Goldman Sachs的Sara Naison-Tarajano与世界上许多最富有的家族合作。作为Goldman的合伙人，她担任私人财富管理资本市场全球主管，以及Goldman Sachs Apex的负责人，该部门为客户家族提供投资交易机会。自2021年以来，Goldman每两年对超级富豪家族办公室的专业人士进行调研，其中三分之二的家族办公室资产超过10亿美元，以深入了解驱动他们投资优先级和前景的因素。鉴于IPO后的估值，这对私人投资者来说是巨大成功。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","LU1668664300.SGD","LU1894683264.USD","LU1868836757.USD","LU1814569148.SGD","BK4532","LU0127658192.USD","BK4551","LU2750360997.AUD","IE00B7SZLL34.SGD","LU2471134879.HKD","SGXZ99366536.SGD","BK4552","BK4127","LU1983260115.SGD","SG9999017495.SGD","LU0251142724.SGD","LU2237957902.USD","LU0353189680.USD","LU0061475181.USD","LU0006306889.USD","IE0002270589.USD","LU0642271901.SGD","LU1791807156.HKD","BK4139","MRNA","BK4536","SGXZ81514606.USD","BK4230","LU1988902786.USD","LU2237443549.SGD","LU0107464264.USD","BK4585","LU0742534661.SGD","LU0082616367.USD","LU2237443465.HKD","IE00BFXG1179.USD","BK4588","IE00BFMHRM44.USD","LU2264538146.SGD","LU2237443622.USD","SG9999014898.SGD","LU1868837136.USD","LU2237957811.SGD","UBER","LU1861219969.SGD","BK4548","LU2750360641.GBP","IE00B19Z3B42.SGD","SGXZ51526630.SGD","LU1894683348.USD","GB00BDT5M118.USD","SG9999015978.USD","SG9999015952.SGD","LU2471134952.CNY","LU0048573561.USD","LU1064131342.USD","LU1804176565.USD","BK4533","IE0034235188.USD","LU2237443895.HKD","LU2087625088.SGD","SGXZ31699556.SGD","BK4116","LU1316542783.SGD","IE0004091025.USD","LU1861214812.USD","SG9999015986.USD","LU0106261372.USD","SG9999014880.SGD","BK4568","BK4550","BK4505","LU1868836914.USD","BK4504","SG9999014906.USD","SG9999014914.USD","LU2237443978.SGD","BK4022","IE00BSNM7G36.USD","SG9999015945.SGD","SG9999018865.SGD","BK4503","LU0096364046.USD","IE00BZ199S13.USD","LU0106831901.USD","LU1868836591.USD","BK4501","LU2237438978.USD","IE00B19Z3581.USD","BK4516","LU0719512351.SGD","LU2265009873.SGD","LU1868837300.USD","SG9999018857.SGD","LU2471134523.USD","LU2471134796.USD","LU0353189763.USD","BK4535","CRWV","LU0251131958.USD","LU2237443382.USD","IE0004086264.USD","LU2360107325.USD"],"gpt_icon":1},{"id":"2567900879","title":"傳特朗普政府計劃指控新冠疫苗導致25名兒童死亡 輝瑞(PFE.US)、Moderna(MRNA.US)股價大跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2567900879","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567900879?lang=zh_tw&edition=fundamental","pubTime":"2025-09-13 07:00","pubTimestamp":1757718000,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"ae8bc75ba4d1918dcafc0476d86c6d53","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0289739699.SGD","LU0868494617.USD","BK4585","BK4548","BK4592","LU0225771236.USD","LU0234572021.USD","IE000M9KFDE8.USD","CDC","LU0170899867.USD","LU0456855351.SGD","BK4139","159646","BK4599","IE0002270589.USD","SG9999003800.SGD","BK4534","BK4532","LU0321505439.SGD","LU1023059063.AUD","SGXZ57979304.SGD","SG9999011175.SGD","LU0321505868.SGD","LU1066053197.SGD","PFE","BK4550","LU1894683264.USD","BK4588","BK4581","BK4501","LU1057294990.SGD","LU1883839398.USD","LU0306806265.USD","LU1066051498.USD","BK4568","IE00BLSP4239.USD","IE00BBT3K403.USD","SG9999002224.SGD","BK4007","LU0985481810.HKD","IE00BLSP4452.SGD","LU0122379950.USD","IE00B19Z3B42.SGD","LU1894683348.USD","IE00B19Z3581.USD","LU0306807586.USD","SG9999001176.SGD","SG9999001176.USD","MRNA","LU0058720904.USD"],"gpt_icon":0},{"id":"2567237905","title":"阿斯利康暫停在英國研發設施的2.71億美元投資。","url":"https://stock-news.laohu8.com/highlight/detail?id=2567237905","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567237905?lang=zh_tw&edition=fundamental","pubTime":"2025-09-13 01:35","pubTimestamp":1757698525,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2456880835.USD","BK4588","BK4568","LU0320765992.SGD","LU0889565916.HKD","BK4585","LU2236285917.USD","LU1829250122.USD","LU0109394709.USD","LU2417539215.USD","LU2462157665.USD","BK4007","AZN"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":96,"code":"91000000","status":"200"}]}}